Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease

201942 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Atherosclerosis

Volume 290, pp. 59-65

Field-Weighted Citation Impact: 6.22